E-mail

E-mail a Wiley Online Library Link

S. Bunnapradist, K. Ciechanowski, P. West-Thielke, S. Mulgaonkar, L. Rostaing, B. Vasudev, K. Budde and on behalf of the MELT investigators Conversion From Twice-Daily Tacrolimus to Once-Daily Extended Release Tacrolimus (LCPT): The Phase III Randomized MELT Trial American Journal of Transplantation 13

Version of Record online: 21 DEC 2012 | DOI: 10.1111/ajt.12035

This phase III noninferiority conversion trial in stable renal transplant recipients demonstrates that a novel extended-release once-daily tacrolimus formulation is noninferior to tacrolimus twice-daily in efficacy failure rates, has a similar safety profile, and requires lower doses to achieve target trough levels.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH